当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析

国药一致

(000028)

  

流通市值:117.31亿  总市值:136.58亿
流通股本:4.78亿   总股本:5.57亿

国药一致(000028)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润2.37亿元,每股收益1.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益2075539.93万元,未分配利润1257555.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产4755586.04万元,负债2680046.11万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入74,378,494,389.5756,466,354,478.3737,785,980,620.9519,090,480,767.9
营业总成本73,017,475,226.7755,384,596,098.9737,024,016,079.618,628,475,913.31
营业利润573,478,281.111,344,444,922.23948,860,093.44544,001,136.48
利润总额575,469,437.321,356,463,270.05957,968,900.2550,249,302.13
净利润237,003,526.491,095,669,310.29770,054,628.11446,123,063.02
其他综合收益-15,541,136.14-13,914.59-13,914.59-
综合收益总额221,462,390.351,095,655,395.7770,040,713.52446,123,063.02
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计37,576,395,698.7740,678,316,958.9639,892,558,310.5340,058,309,136.13
非流动资产合计9,979,464,716.4511,302,538,613.3511,512,683,077.311,466,688,128.88
资产总计47,555,860,415.2251,980,855,572.3151,405,241,387.8351,524,997,265.01
流动负债合计24,802,407,197.7928,092,983,684.0627,673,005,280.5927,722,116,311.2
非流动负债合计1,998,053,899.612,233,506,658.272,383,293,314.92,384,064,495.58
负债合计26,800,461,097.430,326,490,342.3330,056,298,595.4930,106,180,806.78
归属于母公司股东权益合计17,669,528,375.6518,101,879,082.9917,779,820,945.417,803,579,439.13
股东权益合计20,755,399,317.8221,654,365,229.9821,348,942,792.3421,418,816,458.23
负债和股东权益合计47,555,860,415.2251,980,855,572.3151,405,241,387.8351,524,997,265.01
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计80,408,700,561.6156,625,996,162.0237,492,026,106.1116,415,190,745.32
经营活动现金流出小计77,137,232,264.5855,344,904,053.9336,562,648,597.3317,049,336,514.22
经营活动产生的现金流量净额3,271,468,297.031,281,092,108.09929,377,508.78-634,145,768.9
投资活动现金流入小计217,442,245.19216,988,662.2646,593,517.9224,842,270.95
投资活动现金流出小计368,127,854.62288,221,019.36216,000,904.1976,829,236.18
投资活动产生的现金流量净额-150,685,609.43-71,232,357.1-169,407,386.27-51,986,965.23
筹资活动现金流入小计1,824,239,928.711,410,753,157.681,264,981,342.78991,611,668.12
筹资活动现金流出小计3,655,476,076.733,396,976,558.982,311,769,640.15872,571,674.19
筹资活动产生的现金流量净额-1,831,236,148.02-1,986,223,401.3-1,046,788,297.37119,039,993.93
汇率变动对现金及现金等价物的影响-1,196,465.06-1,200,190.66-1,224,255.92,810.99
现金及现金等价物净增加额1,288,350,074.52-777,563,840.97-288,042,430.76-567,089,929.21
期末现金及现金等价物余额7,123,644,530.875,057,730,615.385,547,252,025.595,268,204,527.14
最新报告期:2025-04-10
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中金公司张琎,朱言音1.621.80--2025-04-10
华泰证券代雯,孔垂岩,王殷杰2.542.582.622025-04-08
西南证券杜向阳,汪翌雯1.152.372.682025-03-20
TOP↑